No Shortage Of Moxie At Nymox

Did the drugmaker jump the gun in selling its Alzheimer's test?

In late 1996, Nymox Pharmaceutical Corp., a little-known Montreal drug company, ran an ad in TV Guide for a new diagnostic test for Alzheimer's disease. "Alzheimer's--Now you can rule it out," the copy said. It offered the promise of relief to worried patients and their families. The only problem, some scientists say, was that the ad was misleading. The test was unproven, they say, and the company's claim that it could "rule out" the dread ailment was unsupported by published data or scientific consensus.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.